Comparing two iron supplements for treating anemia in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of two commonly used iron supplements, Ferrous Sulphate and Iron Polymaltose Complex, in treating iron deficiency anemia in pediatric patients. The research aims to evaluate their efficacy, bioavailability, side effects, and cost to determine which preparation is more beneficial for children in the local population. By analyzing these factors, the study seeks to provide clearer guidance for pediatricians in managing this prevalent condition. The trial will include children diagnosed with iron deficiency anemia while excluding those with certain blood disorders or gastrointestinal issues.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients having iron deficiency anemia

Exclusion Criteria:

1. Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record).
2. Patients who were transfused in previous 4 weeks (will be determined on history)
3. Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record)
4. Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools.

Where it's running

• Khyber Teaching Hospital
  Peshawar, Kpk, Pakistan Recruiting

Study contacts

• Study coordinator: Aimal Khan, MBBS
• Email: aimalkhan871207@gmail.com
• Phone: 03481903336

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia

  This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.

  Recruiting Phase 4 Weill Medical College of Cornell University · New York, New York · NCT07925450

• Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants

  In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.

  Recruiting AdventHealth · Orlando, Florida · NCT07816601

• Preconception versus early-pregnancy iron screening and treatment

  This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.

  Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Zhaotong, Yunnan · NCT07811765

• Ferric derisomaltose injection in adults with iron deficiency anemia under fasting conditions

  This study tests whether a ferric derisomaltose injection given to adults with iron deficiency anemia in a fasting state works similarly to a reference product and is safe to use.

  Recruiting Phase 1 Sichuan Huiyu Pharmaceutical Co., Ltd · Zhengzhou · NCT07790562

• FACE-APPS approach to improve iron in adolescent girls in marginalized communities

  This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.

  Recruiting Cairo University · Wadi Addawasir, Wadi Addawasir Governorate · NCT07633262

• Acupoint TENS vs. Resistance Training for Iron Deficiency Anemia in Women

  This trial tests whether acupoint transcutaneous electrical nerve stimulation (Acu-TENS) or resistance exercise, in addition to standard care, can raise hemoglobin levels in women with iron deficiency anemia.

  Recruiting Phase 4 Cairo University · Cairo · NCT07605676

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.